APA (7th ed.) Citation

Friedman, S. M., Xu, Y., Sherman, S., Kuznik, A., Mojebi, A., Keeping, S., . . . Patel, N. (2026). A Response to: Letter to the Editor Regarding “Aflibercept 8 mg Versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials”. Ophthalmology & Therapy, 1. https://doi.org/10.1007/s40123-026-01439-5

Chicago Style (17th ed.) Citation

Friedman, Scott M., Yingxin Xu, Steven Sherman, Andreas Kuznik, Ali Mojebi, Sam Keeping, Keith Chan, Theodore Leng, and Nimesh Patel. "A Response to: Letter to the Editor Regarding “Aflibercept 8 mg Versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials”." Ophthalmology & Therapy 2026: 1. https://doi.org/10.1007/s40123-026-01439-5.

MLA (9th ed.) Citation

Friedman, Scott M., et al. "A Response to: Letter to the Editor Regarding “Aflibercept 8 mg Versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials”." Ophthalmology & Therapy, 2026, p. 1, https://doi.org/10.1007/s40123-026-01439-5.